Results 11 to 20 of about 58,147 (226)
Cardiovascular Involvement in Tuberculosis Patients Treated in Southern Africa
Background: Tuberculosis (TB) is the leading cause of death among people with HIV and a major global health challenge. Subclinical cardiovascular manifestations of TB are poorly documented in high TB and HIV burden countries.
Daryoush Samim, MD +12 more
doaj +3 more sources
Tuberculosis and Cardiovascular Complications: An Overview
Tuberculosis (TB) is a dominant cause of mortality from a single infectious disease agent. It is a global health issue that has been tagged as a public health emergency for decades. The disease process, which is caused by Mycobacterium tuberculosis (MTB), affects the respiratory system as well as many other organ systems in the body, such as the ...
Adefuye, Mayowa A +5 more
openaire +2 more sources
The association of atherosclerotic cardiovascular disease and statin use with inflammation and treatment outcomes in tuberculosis [PDF]
AbstractTuberculosis (TB) and atherosclerotic cardiovascular disease (ASCVD) have a close epidemiological and pathogenetic overlap. Thus, it becomes essential to understand the relationship between ASCVD and TB outcomes. From our retrospective cohort on drug-susceptible TB patients at the National Taiwan University Hospital, we assessed the association
Jennie Ruelas Castillo +8 more
openaire +4 more sources
Tuberculosis and cardiovascular disease: linking the epidemics [PDF]
The burden of tuberculosis and cardiovascular disease (CVD) is enormous worldwide. CVD rates are rapidly increasing in low- and middle-income countries. Public health programs have been challenged with the overlapping tuberculosis and CVD epidemics. Monocyte/macrophages, lymphocytes and cytokines involved in cellular mediated immune responses against ...
Timothy R. Sterling +4 more
openaire +3 more sources
Major adverse cardiovascular events and hyperuricemia during tuberculosis treatment
Background Hyperuricemia is common during tuberculosis (TB) treatment, especially in association with pyrazinamide (PZA). This study investigated the relationship between major adverse cardiovascular events (MACEs) and hyperuricemia during TB treatment. Methods We conducted a single-center retrospective cohort study.
Hong-Joon Shin +9 more
openaire +4 more sources
Cardiovascular risk factors among people with drug-resistant tuberculosis in Uganda
Abstract Background Tuberculosis (TB) and its risk factors are independently associated with cardiovascular disease (CVD). We determined the prevalence and associations of CVD risk factors among people with drug-resistant tuberculosis (DRTB) in Uganda.
Baluku, Joseph Baruch +10 more
openaire +5 more sources
The effect of fasting on spirometry indices and respiratory symptoms in asthmatic patients [PDF]
Introduction: Ramadan can alter the course of diseases by changing nutrition patterns, sleep habits, and medication-taking schedules. There are some concerns that patients with asthma may be affected by these alterations during Ramadan and experience ...
Mohammad Reza Ghaffary +3 more
doaj +1 more source
Although primarily a lung disease, extra-pulmonary tuberculosis (TB) can affect any organ or system. Of these, cardiovascular complications associated with disease or drug toxicity significantly worsen the prognosis. Approximately 60% of patients with TB have a cardiovascular disease, the most common associated pathological entities being pericarditis,
Dragos Traian Marius Marcu +7 more
openaire +3 more sources
Cinnamic Acid Derivatives in Tuberculosis, Malaria and Cardiovascular Diseases - A Review [PDF]
Cinnamic acid and its phenolic analogues are natural substances. Chemically, cinnamic acids or the 3-phenyl acrylic acids, offer three main reactive sites: substitution on the phenyl ring, addition on the α ,β -unsaturation and reactions of the carboxylic acid.
De, Prithwiraj +3 more
openaire +3 more sources
The objective: to evaluate expanded monitoring of cardiovascular disorders in older children and adolescents with multiple drug resistant tuberculosis receiving bedaquiline (Bq) as a part of anti-tuberculosis therapy.Subjects and Methods: A cohort ...
O. A. Piskunova +4 more
doaj +1 more source

